Key points are not available for this paper at this time.
Treating localized prostate cancer with moderate H-RT could reduce national health insurance spending. Adopting such a treatment with an updated reimbursement tariff would result in improving resource allocation in RT management.
Zhou et al. (Mon,) studied this question.